Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-268106
Filing Date
2024-11-29
Accepted
2024-11-29 16:19:06
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 d907660ds3.htm S-3 283122
2 EX-5.1 d907660dex51.htm EX-5.1 27582
3 EX-23.1 d907660dex231.htm EX-23.1 1781
4 EX-FILING FEES d907660dexfilingfees.htm   iXBRL EX-FILING FEES 42574
5 GRAPHIC g907660g03k03.jpg GRAPHIC 42493
6 GRAPHIC g907660g08k08.jpg GRAPHIC 194037
  Complete submission text file 0001193125-24-268106.txt   815354

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT d907660dexfilingfees_htm.xml XML 6593
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283533 | Film No.: 241516560
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)